Ilsung Pharmaceuticals Co., Ltd. 003120.KS Stock
Ilsung Pharmaceuticals Co., Ltd. Price Chart
Ilsung Pharmaceuticals Co., Ltd. 003120.KS Financial and Trading Overview
Ilsung Pharmaceuticals Co., Ltd. stock price | 20050 KRW |
Previous Close | 21850 KRW |
Open | 22500 KRW |
Bid | 21750 KRW x N/A |
Ask | 21800 KRW x N/A |
Day's Range | 21650 - 22500 KRW |
52 Week Range | 15640 - 38000 KRW |
Volume | 1.76K KRW |
Avg. Volume | 9.68K KRW |
Market Cap | 150.29B KRW |
Beta (5Y Monthly) | -0.212931 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | 4000 (18.31%) |
Ex-Dividend Date | December 28, 2022 |
1y Target Est | N/A |
003120.KS Valuation Measures
Enterprise Value | -94237016064 KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.1139352 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | -1.326 |
Enterprise Value/EBITDA | -800.209 |
Trading Information
Ilsung Pharmaceuticals Co., Ltd. Stock Price History
Beta (5Y Monthly) | -0.212931 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 38000 KRW |
52 Week Low | 15640 KRW |
50-Day Moving Average | 25206 KRW |
200-Day Moving Average | 23534.15 KRW |
003120.KS Share Statistics
Avg. Volume (3 month) | 9.68K KRW |
Avg. Daily Volume (10-Days) | 7.73K KRW |
Shares Outstanding | 6.82M |
Float | 2.5M |
Short Ratio | N/A |
% Held by Insiders | 44.56% |
% Held by Institutions | 0.67% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | 310.00% |
Payout Ratio | 0.30020002 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 26.84% |
Operating Margin (ttm) | -4.66% |
Gross Margin | 49.70% |
EBITDA Margin | 0.16% |
Management Effectiveness
Return on Assets (ttm) | -0.44% |
Return on Equity (ttm) | 4.45% |
Income Statement
Revenue (ttm) | 71.09B KRW |
Revenue Per Share (ttm) | 9578.3 KRW |
Quarterly Revenue Growth (yoy) | 53.50% |
Gross Profit (ttm) | 27.82B KRW |
EBITDA | 117.77M KRW |
Net Income Avi to Common (ttm) | 19.09B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 248.74B KRW |
Total Cash Per Share (mrq) | 35222.8 KRW |
Total Debt (mrq) | 199.18M KRW |
Total Debt/Equity (mrq) | 0.05 KRW |
Current Ratio (mrq) | 13.239 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -352810598400 KRW |
Levered Free Cash Flow (ttm) | -95216377856 KRW |
Profile of Ilsung Pharmaceuticals Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 84-gil 9, Wonhyo-ro |
ZIP | N/A |
Phone | 82 2 3271 8800 |
Website | https://www.ilsung-ph.co.kr |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.
Q&A For Ilsung Pharmaceuticals Co., Ltd. Stock
What is a current 003120.KS stock price?
Ilsung Pharmaceuticals Co., Ltd. 003120.KS stock price today per share is 20050 KRW.
How to purchase Ilsung Pharmaceuticals Co., Ltd. stock?
You can buy 003120.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ilsung Pharmaceuticals Co., Ltd.?
The stock symbol or ticker of Ilsung Pharmaceuticals Co., Ltd. is 003120.KS.
Which industry does the Ilsung Pharmaceuticals Co., Ltd. company belong to?
The Ilsung Pharmaceuticals Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ilsung Pharmaceuticals Co., Ltd. have in circulation?
The max supply of Ilsung Pharmaceuticals Co., Ltd. shares is 6.82M.
What is Ilsung Pharmaceuticals Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Ilsung Pharmaceuticals Co., Ltd. PE Ratio is now.
What was Ilsung Pharmaceuticals Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Ilsung Pharmaceuticals Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Ilsung Pharmaceuticals Co., Ltd. company belong to?
The Ilsung Pharmaceuticals Co., Ltd. sector is Healthcare.